Request Free Sample ×
South America Custom Antibody Market Research Report- Forecast To 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Custom Antibody Market

ID: MRFR/MED/51853-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

South America Custom Antibody Market Research Report By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labelling), By Source (Mice, Others), By Research Area (Oncology, Neurobiology, Infectious Diseases, Immunology, Others), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibody, Other Custom Antibodies), By End Users (Hospitals & Clinics, Academic & Research Institute, Contact Research Organization, Biotechnology Companies, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) -Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Custom Antibody Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Service (USD Million)
      1. 4.1.1 Antibody Development
      2. 4.1.2 Antibody Production & Purification
      3. 4.1.3 Antibody Fragmentation & Labelling
    2. 4.2 Construction, BY Source (USD Million)
      1. 4.2.1 Mice
      2. 4.2.2 Others
    3. 4.3 Construction, BY Research Area (USD Million)
      1. 4.3.1 Oncology
      2. 4.3.2 Neurobiology
      3. 4.3.3 Infectious Diseases
      4. 4.3.4 Immunology
      5. 4.3.5 Others
    4. 4.4 Construction, BY Type (USD Million)
      1. 4.4.1 Monoclonal Antibodies
      2. 4.4.2 Polyclonal Antibodies
      3. 4.4.3 Recombinant Antibody
      4. 4.4.4 Other Custom Antibodies
    5. 4.5 Construction, BY End Users (USD Million)
      1. 4.5.1 Biotechnology Companies
      2. 4.5.2 Hospital & Clinics
      3. 4.5.3 Academic & Research Institutes
      4. 4.5.4 Contract Research Organizations
      5. 4.5.5 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abcam (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 GenScript (CN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Merck KGaA (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bio-Rad Laboratories (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cell Signaling Technology (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Santa Cruz Biotechnology (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 R&D Systems (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY SERVICE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY SOURCE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY RESEARCH AREA
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TYPE
    6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY END USERS
    7. 6.7 KEY BUYING CRITERIA OF CONSTRUCTION
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CONSTRUCTION
    10. 6.10 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    12. 6.12 SUPPLY / VALUE CHAIN: CONSTRUCTION
    13. 6.13 CONSTRUCTION, BY SERVICE, 2024 (% SHARE)
    14. 6.14 CONSTRUCTION, BY SERVICE, 2024 TO 2035 (USD Million)
    15. 6.15 CONSTRUCTION, BY SOURCE, 2024 (% SHARE)
    16. 6.16 CONSTRUCTION, BY SOURCE, 2024 TO 2035 (USD Million)
    17. 6.17 CONSTRUCTION, BY RESEARCH AREA, 2024 (% SHARE)
    18. 6.18 CONSTRUCTION, BY RESEARCH AREA, 2024 TO 2035 (USD Million)
    19. 6.19 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    20. 6.20 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 CONSTRUCTION, BY END USERS, 2024 (% SHARE)
    22. 6.22 CONSTRUCTION, BY END USERS, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE, 2025-2035 (USD Million)
      2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
      3. 7.2.3 BY RESEARCH AREA, 2025-2035 (USD Million)
      4. 7.2.4 BY TYPE, 2025-2035 (USD Million)
      5. 7.2.5 BY END USERS, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America Construction Market Segmentation

Construction By Service (USD Million, 2025-2035)

  • Antibody Development
  • Antibody Production & Purification
  • Antibody Fragmentation & Labelling

Construction By Source (USD Million, 2025-2035)

  • Mice
  • Others

Construction By Research Area (USD Million, 2025-2035)

  • Oncology
  • Neurobiology
  • Infectious Diseases
  • Immunology
  • Others

Construction By Type (USD Million, 2025-2035)

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibody
  • Other Custom Antibodies

Construction By End Users (USD Million, 2025-2035)

  • Biotechnology Companies
  • Hospital & Clinics
  • Academic & Research Institutes
  • Contract Research Organizations
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓